Real-world effectiveness and safety of psychedelic-assisted psychotherapy: Outcomes from a large-scale compassionate use cohort in Switzerland
Top Cited Papers
Open Access
- 2 February 2026
- journal article
- Published by Elsevier in Psychiatry Research
- Vol. 358, 116992
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Efficacy and safety of low- versus high-dose-LSD-assisted therapy in patients with major depression: A randomized trialMed, 2025
- Clinical and preclinical evidence of psilocybin as antidepressant. A narrative reviewProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2025
- Therapeutic potential of psychedelics: History, advancements, and unexplored frontiersProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2024
- Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studiesEuropean Neuropsychopharmacology, 2023
- A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugsEuropean Neuropsychopharmacology, 2022
- Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II StudyBiological Psychiatry, 2022
- Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approachNeurobiology of Learning and Memory, 2021
- Effects of Psilocybin-Assisted Therapy on Major Depressive DisorderJAMA Psychiatry, 2021
- Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxietyJournal of Contextual Behavioral Science, 2019
- An Inventory for Measuring DepressionArchives of General Psychiatry, 1961